Jacroux Richard — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Jacroux Richard is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Richard Jacroux is the Chief Financial Officer of ENDRA Life Sciences Inc., as disclosed in the SEC filing dated January 24, 2026 (CIK 0002033818). The filing indicates his role as a corporate insider with no reported purchases or sales in that period. ENDRA Life Sciences develops Thermo Acoustic Enhanced Ultrasound (TAEUS) technology for tissue visualization at the point of care.
Role
Insider
Notability
45/100
Board memberships
ENDRA Life Sciences Inc.
Awards & honors
Oversees financial reporting and compliance for ENDRA Life Sciences
Manages corporate finance activities and capital structure
Richard Jacroux is the Chief Financial Officer of ENDRA Life Sciences Inc., as disclosed in the SEC filing dated January 24, 2026 (CIK 0002033818). The filing indicates his role as a corporate insider with no reported purchases or sales in that period. ENDRA Life Sciences develops Thermo Acoustic Enhanced Ultrasound (TAEUS) technology for tissue visualization at the point of ca…
Where can I see all of Jacroux Richard's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
